Developing a Core outcome set of Traditional Chinese Medicine on Stroke

Stroke is a sudden disorder of cerebral blood circulation disease and is divided into acute phase, recovery stage and poststroke syndrome period, which has high incidence rate, lethality rate and disability rate. After the onset of stroke, most of them left some sequelae symptoms, such as dyskinesia, dysphagia and depression. In recent years, the incidence rate of stroke has been increasing year by year, and the age of onset is getting younger. Every year, 5% people in the world suffer from stroke, and more than 5 million patients die of stroke. China is a high incidence area of stroke, which has about 240 new cases every year and the incidence rate is 13.9% per years. About 75% of the survivors have sequelae, 40% of them are severely disabled. Currently, it is the first cause of death in China, which brings huge economic and living burden to the society and patients.

At present, there are no specific treatments for stroke in western medicine clinic, and long-term treatments show great toxic and side effects. However, traditional Chinese medicine in the treatment of stroke have a certain clinical efficacy, and the relevant clinical researches have increased year by year. However, most clinical studies have some problems such as large difference in the selection of outcome indicators, unreported/incomplete report of important outcome indicators, and insufficient reporting of outcome indicators measurement tools/methods. Therefore, it is very necessary and urgent to establish a Core outcome set (COS) on TCM for stroke by scientific research methods.

Contributors

Ting Zhang. Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine;
Mingyan Zhang. Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine;
Bohan Niu. Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine;
Jinhui Tian. Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University;
Junhua Zhang. Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine.

Further Study Information

Current Stage: Planning
Date: October 2020 - December 2022
Funding source(s): None


Health Area

Disease Category: Neurology

Disease Name: Stroke

Target Population

Age Range: 40 - 100

Sex: Either

Nature of Intervention: Complementary and alternative medicine (CAM) therapy, Traditional Chinese Medicine

Stakeholders Involved

- Clinical experts
- Consumers (caregivers)
- Consumers (patients)
- Epidemiologists
- Journal editors
- Methodologists
- Patient/ support group representatives
- Researchers
- Statisticians

Study Type

- COS for practice

Method(s)

- Consensus meeting
- Delphi process
- Interview
- Systematic review

1. Systematic literature review;
2. Qualitative semi-structured interviews;
3. Two rounds Delphi survey;
4. Consensus conference

Linked Studies

    No related studies


Related Links